References

• 2021The PRISMA 2020 statement: an updated guideline for reporting systematic reviews107,380 cited
• 2017AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both10,605 cited
• 2011GRADE guidelines: 3. Rating the quality of evidence8,270 cited
• 2021Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic5,433 cited
• 2009When does age-related cognitive decline begin?1,846 cited
• 2018Prevalence of Depression in the Community from 30 Countries between 1994 and 20141,556 cited
• 2008The Evolution of the Cognitive Model of Depression and Its Neurobiological Correlates1,532 cited
• 2016Scaling-up treatment of depression and anxiety: a global return on investment analysis1,448 cited
• 1993Response styles and the duration of episodes of depressed mood.1,212 cited
• 2010Understanding depressive rumination from a cognitive science perspective: The impaired disengagement hypothesis915 cited
• 2011A meta-analysis of the effect of cognitive bias modification on anxiety and depression.890 cited
• 2010Attention Bias Modification Treatment: A Meta-Analysis Toward the Establishment of Novel Treatment for Anxiety869 cited
• 2010A meta-analysis of the magnitude of biased attention in depression646 cited